Category Pharmaceutical Industry

The U.S. Healthcare Reform: Impact on the Pharmaceutical Industry

Jul29

Research and Markets has announced the addition of Decision Resources, Inc.’s new report "U.S. Healthcare Reform: Impact on the Pharmaceutical Industry" to their offering (see also Biologics).Healthcare reform is coming to the United States and everyone is asking, Whats in it for me? The debate to pass healthcare reform into law was long and contentious, [...]

Catheter Connections Receives 510k Clearance From FDA For DualCap Vascular Access Disinfecting Cap

Jul29

Catheter Connections, Inc., a manufacturer of innovative vascular access and infection control products, announced that the U.S. Food and Drug Administration (FDA) has granted the company 510(k) clearance to market its DualCap? product. DualCap is the only device that nests two disinfecting caps together – for both IV access points, the needleless injection site (NIS) [...]

Hospira to test generic anemia drug: Health care reform prompts interest in ‘biosimilar’ biotech drugs [Chicago Tribune]

Jul28

July 29In the wake of health reform’s passage into law, Hospira Inc. will begin testing a cheaper version of a popular anemia biotech treatment in the first phase of a U.S. clinical trial.Lake Forest-based Hospira said it will begin the first phase of trials for a "biosimilar," or a biogeneric, version of brand-name Epogen in [...]

Local business briefs

Jul28

July 29WILMINGTON PPD Inc. and Microsoft Corp. have agreed to jointly develop technology to improve efficiency in managing risk evaluation and mitigation strategy programs mandated by the U.S. Food and Drug Administration.The technology will be based on the Microsoft Amalga Unified Intelligence System, a data aggregation platform that gives health care professionals access to [...]

Great News From Stock Marketing Inc.!! Sign Up Today!! VKNG,NPHC,GORO,ARYC,NSATF,NLEF

Jul28

STOCK MARKETING INC PRESENTS : (OTCBB: VKNG) Viking Systems, Inc., (OTCBB: NPHC) Nutra Pharma Corp., (OTCBB: GORO) Gold Resource Corp., (OTCBB: ARYC) Arrayit Corp., (OTCBB: NSATF) Norsat International Inc., (OTCBB: NLEF) New Leaf Brands, Inc.www.StockMarketingInc.comFor More Information email us!! Steve@StockMarketingInc.com
(OTCBB: VKNG – Viking Systems, Inc.)LATEST NEWS!!Viking Systems and Boston Scientific Extend Supply ContractWESTBOROUGH, Mass., Jul [...]

Check Out Stock Marketing Inc Today!! NPHC,GNBT,VKNG,ISCO,AJGH,NWCI:: Sign Up Today!!

Jul28

STOCK MARKETING INC PRESENTS : (OTCBB: NPHC) Nutra Pharma Corp., (NASDAQ: GNBT) Generex Biotechnology Corp., (OTCBB: VKNG) Viking Systems, Inc., (OTCBB: ISCO) International Stem Cell Corp., (OTCBB: AJGH) American Jianye Greentech Holdings Inc., (OTCBB: NWCI) Newcardio, Inc.www.StockMarketingInc.comFor More Information email us!! Steve@StockMarketingInc.com
(OTCBB: NPHC – Nutra Pharma Corp.)LATEST NEWS!!Nutra Pharma Receives Patent for Novel Antiviral Treatment [...]

Boston Scientific Announces FDA Approval of New Leads for the Precision Plus? Spinal Cord Stimulator System

Jul28

NATICK, Mass., July 29 /PRNewswire-FirstCall/ Boston Scientific Corporation (NYSE: BSX) today announced U.S. Food and Drug Administration approval of two spinal cord stimulation (SCS) leads for use with its Precision Plus? Spinal Cord Stimulator System, the world's first rechargeable SCS device for the management of chronic pain of the trunk and/or limbs. The Linear? [...]

Antisoma’s preliminary results for the year ended 30 June 2010

Jul28

London, UK, and Cambridge, MA: 29 July 2010 Antisoma plc (LSE: ASM; USOTC:ATSMY) today announces its preliminary results for the year ended 30 June 2010.These results have been prepared under International Financial ReportingStandards (’IFRS’) as adopted for use by the European Union.Key events of 2009/2010AS1413 * Positive final data reported from secondary AML phase [...]

Bionovo to Advance Menerba to Phase 3 Clinical Testing in Europe

Jul28

EMERYVILLE, Calif., July 29 /PRNewswire-FirstCall/ Bionovo, Inc. (Nasdaq: BNVI) announced today that it has received final guidance from the European Medicines Agency (EMA) in order to advance Menerba, the company's lead drug candidate for menopausal symptoms, to Phase 3 clinical trials in Europe. The guidance defines the clinical and regulatory pathway to a European [...]

Global Health Ventures to Initiate Prototype Manufacturing of a Sublingual Anti-Anxiety Drug

Jul28

VANCOUVER, BRITISH COLUMBIA (MARKET WIRE) 07/29/10 Global Health Ventures Inc. (OTCBB: GHLV) (the "Company"), a specialty pharmaceutical company today announced that it has signed an agreement with Carter Pharmaceutical of Toronto, Canada, to manufacture the prototype of its anti-anxiety drug "Relax-B". Together, the companies will manufacture about 10,000 pills for carrying [...]

Your Ad Here